SteelPeak Wealth’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Buy
+17,198
New +$241K 0.01% 538
2026
Q1
Sell
-21,006
Closed -$189K 623
2025
Q4
$189K Buy
+21,006
New +$289K 0.01% 499
2025
Q1
Sell
-16,106
Closed -$188K 647
2024
Q4
$188K Sell
16,106
-3,000
-16% -$46.8K 0.01% 492
2024
Q3
$393K Buy
+19,106
New +$441K 0.02% 352
2024
Q2
Sell
-8,309
Closed -$229K 585
2024
Q1
$229K Buy
+8,309
New +$231K 0.01% 406
2023
Q4
Sell
-8,308
Closed -$263K 489
2023
Q3
$263K Sell
8,308
-1,851
-18% -$71.8K 0.02% 349
2023
Q2
$414K Sell
10,159
-3,467
-25% -$141K 0.02% 269
2023
Q1
$508K Buy
13,626
+4,511
+49% +$177K 0.03% 240
2022
Q4
$318K Sell
9,115
-3,997
-30% -$190K 0.02% 300
2022
Q3
$734K Sell
13,112
-1,605
-11% -$99.6K 0.06% 189
2022
Q2
$762K Buy
14,717
+362
+3% +$18.4K 0.05% 199
2022
Q1
$1.04M Buy
14,355
+6,550
+84% +$555K 0.06% 184
2021
Q4
$923K Sell
7,805
-2,179
-22% -$273K 0.06% 185
2021
Q3
$1.34M Sell
9,984
-1,537
-13% -$233K 0.09% 136
2021
Q2
$1.86M Buy
11,521
+1,080
+10% +$84.1K 0.14% 118
2021
Q1
$838K Buy
10,441
+4,038
+63% +$271K 0.07% 177
2020
Q4
$348K Buy
+6,403
New +$233K 0.03% 248

Other funds holding NTLA